Integrated treatment using intraperitoneal radioimmunotherapy and positron emission tomography-guided surgery with 64Cu-labeled cetuximab to treat early- and late-phase peritoneal dissemination in human gastrointestinal cancer xenografts.
about
Integrated treatment using intraperitoneal radioimmunotherapy and positron emission tomography-guided surgery with 64Cu-labeled cetuximab to treat early- and late-phase peritoneal dissemination in human gastrointestinal cancer xenografts.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Integrated treatment using int ...... ointestinal cancer xenografts.
@en
Integrated treatment using int ...... ointestinal cancer xenografts.
@nl
type
label
Integrated treatment using int ...... ointestinal cancer xenografts.
@en
Integrated treatment using int ...... ointestinal cancer xenografts.
@nl
prefLabel
Integrated treatment using int ...... ointestinal cancer xenografts.
@en
Integrated treatment using int ...... ointestinal cancer xenografts.
@nl
P2093
P2860
P356
P1433
P1476
Integrated treatment using int ...... rointestinal cancer xenografts
@en
P2093
Eiji Yoshida
Hideaki Tashima
Hidekatsu Wakizaka
Hiroki Matsumoto
Hiroyuki Takuwa
Ming-Rong Zhang
Mitsuyoshi Yoshimoto
Sayaka Hanadate
Taiga Yamaya
P2860
P304
28935-28950
P356
10.18632/ONCOTARGET.25649
P407
P577
2018-06-22T00:00:00Z